PharmD Live

FEBRUARY 17, 2022

COVID-19 has profoundly changed the world we live in today and will continue to leave an indelible mark long after the pandemic has ended. One area of concern for both health care providers and their patients is the long-term effect of COVID-19 infection on patients with chronic diseases.

Hospitals 52

Hospitals Documentation Labelling 52

PharmD Live

DECEMBER 21, 2021

Practitioners are cautious about its effectiveness, and Medicare has not decided whether to include it in its formulary. See it here. New Standard for Blood Pressure in Chronic Kidney Disease. Meanwhile, quality performance pay is increasing. The average of the increases is 49%. Aduhelm earns FDA approval.

FDA 52

FDA Hospitals 52

pharmaphorum

SEPTEMBER 30, 2021

This Blood Cancer Awareness Month, Blood Cancer UK’s Kate Keightley explains the need for better awareness and understanding of this common, but less-understood disease. This year our community faces some particular challenges as the scale of COVID’s impact becomes clearer. Effects of the pandemic on the blood cancer community.

Vaccines 52

Vaccines Communication 52

PharmD Live

APRIL 20, 2022

1 Obesity increases the risk for many health problems, such as type 2 diabetes, high blood pressure, heart disease, stroke, joint disorders, liver disease, gallstones, some types of cancer, and sleep apnea among other conditions. It’s the first GLP-1 agonist approved for weight loss since approving Saxenda (Liraglutide) in 2014.

Hospitals 52

Hospitals FDA 52

The FDA Law Blog

DECEMBER 11, 2023

It is not entirely clear how many comments were actually logged in; on December 7, FDA showed 19,655 comments, and the next day 6,732.) (It is not entirely clear how many comments were actually logged in; on December 7, FDA showed 19,655 comments, and the next day 6,732.) By Allyson B.

FDA 69

FDA Research Laboratories Documentation 69